Antimicrobial Susceptibility Patterns Of Salmonella Species In Contemporary Medical Practice: Challenges And Prospects In Treatment Of Enteric Fevers by Jombo, GTA et al.
 
GLOBAL JOURNAL OF COMMUNITY MEDICINE VOL. 2 NO. 1 & 2 2009: 5 - 11  
COPYRIGHT© BACHUDO SCIENCE CO. LTD PRINTED IN NIGERIA. ISSN 1597 – 9857 
ANTIMICROBIAL SUSCEPTIBILITY PATTERNS OF 
SALMONELLA SPECIES IN CONTEMPORARY MEDICAL 
PRACTICE: CHALLENGES AND PROSPECTS IN 
TREATMENT OF ENTERIC FEVERS 
 
     G. T. A.  JOMBO, M. N. O. ENENEBEAKU AND S. J. UTSALO 





Treatment of enteric fever is increasingly becoming very challenging due to the increasing wave of 
antibiotic resistance. This study is a review of the contemporary antimicrobial susceptibility pattern of 
Salmonella species. The antimicrobial susceptibility pattern of Salmonella species to a wide range of 
antimicrobial agents was compiled for a period of 10 years (1997-2006). Data was obtained from 
published articles on both in vitro and in vivo susceptibility patterns of the organism to various drugs 
during the time interval. Data obtained were analysed using simple descriptive methods. Of the 23,504 
isolates of Salmonella species reviewed, they were found to be 98% susceptible to cefepime and 
carbapenem, 91% to azithromycin, 82.1% to cefixime and 73% to quinolones. Also susceptibility to 
chloramphenicol, erythromycin, streptomycin, ampicillin, gentamicin, co-trimoxazole, augmentin and 
amikacin was found to be 11.9%, 10.9%, 13.0%, 16.8%, 46.3%, 38.0%, 54.3%, 6.9% and 63.0% 
respectively. This review has demonstrated increasing resistance of Salmonella species to antibiotics. 
Empirical treatment for enteric fevers should, therefore, be discouraged while quinolones, cefepime, 
carbapenem, azithromycin and third generation cephalosporins be given preference.  
 




 In the 21st century, enteric fever in the 
developed world is not much a disease of public 
health importance (Meltzer, et al., 2006; 
Agbakwuru, et al., 2003; and Mba, 2001). The 
disease however continues to occupy the central 
position among diseases of public health 
importance in parts of middle east, India and 
south-east Asia, parts of Latin America, the 
Caribbean, and sub-Saharan Africa where it is 
still endemic (Steinberg, et al., 2004; Nkuo-Akenji 
T, et al., 2001; and Fuller, et al., 2004). 
One of the major challenges now in the 
management of typhoid fevers is the prevailing 
nature of the antimicrobial resistance patterns of 
Salmonella species (Parry, et al., 2007; Na’aya, 
et al., 2004; and Rathore, et al., 1996). In a study 
carried out in Tadjikistan (Makhnev, 2001) 
involving 14 antimicrobial agents representing 
almost all basic chemical classes against 
Salmonella spp., there was no absolute (100%) 
efficacy of the investigated agents in vivo and 
invitro. In Saudi Arabia (Al-Tawfig, 2007), the 
susceptibility pattern of Salmonella typhi/paratyhi 
was reported as 81.3%/56%, 89%/77%, and 
89%/84% susceptible to tetracycline, ampicillin, 
and trimethoprim-sulfamethoxazole respectively. 
Also 100% susceptibility was recorded for 
ceftriaxone and ciprofloxacin while multidrug 
resistance (MDR) was detected in 20% of the 
266 Salmonella spp. Studied. In another study in 
Vietnam (Chinh, et al., 2000), 78%(68 out of 87) 
MDR and 53% nalidixic acid resistance was 
reported among adult males in a University 
Teaching Hospital typhoid ward  in Ho Chi Minh 
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city. Similar but varied patterns of resistance 
have as well been reported in Japan (Tamura, et 
al., 2002), Nigeria (Akinyemi, et al., 2005), and 
Brazil (Alecrim, et al., 2002). 
In the tropical and sub-tropical regions of 
the world, more often than not, physicians result 
to empirical treatment for suspected typhoid 
fevers (loosely including paratyhoid fever) 
(Glauser, et al., 2002; and Oboegbulam, et al., 
1995). Most a times as a result of either, delays 
in the release of laboratory reports, or due to 
outright lack of appropriate diagnostic laboratory 
facilities (Bates, and Maitland, 2006). A proper 
understanding of the current antimicrobial 
susceptibility patterns of Salmonella spp. 
becomes essential. Such information would be 
useful to clinicians who are often confronted with 
the limitations of unreliable or absent 
microbiological results in the course of managing 
typhoid patients Makhnev, 2003; and Moulin, et 
al., 2003). This therefore informed the need for 
the present study.   
 
MATERIALS AND METHODS 
 
 A systematic literature search on 
antimicrobial susceptibility pattern of Salmonella 
species was undertaken on published articles for 
a 10 year interval (1997-2006). This consists of 
articles on both in vivo and in vitro antimicrobial 
susceptibility pattern of individual isolates of 
Salmonella typhi and Salmonella paratyphi on a 
wide range of antibiotics in various research 
centres across the globe. In vivo susceptibility 
reports based on the diagnosis of enteric fevers 
through serological methods were as well 
considered. The in vitro results were 
standardized by collating findings from studies 
whose methodologies were based on the 
diffusion and dilution methods of National 
Committee for Clinical Laboratory Standards 
(NCCLS) protocol. On the other hand the results 
obtained from the in vivo susceptibilities were 
standardized by collating data generated from 
monotherapies. Data obtained was analysed 
using simple descriptive methods. 




 Of the 23,504 isolates of Salmonella 
species reviewed, susceptibility to quinolones on 
average was found to be 73%(n=23,104), 
cefixime 82.1%(n=16,452), ceftriaxone 
78.1%(n=11,701), azithromycin 91%(n=789), and 
chloramphenicol 11.9%(n=13,937). Also 
erythromycin, streptomycin, ampicillin, and 
gentamicin were found to be 10.9 %(n=17,776), 
13.0%(n=873), 16.8%(n=18,329), and 
46.3%(n=19,112) sensitive respectively. Co-
trimoxazole, augmentin, tetracycline, cefepime, 
carbapenem and amikacin were found to be 
38%(n=19,112), 54.3%(n=19,112), 
6.9%(n=19,112), 98%(n=673), 98%(n=555) and 
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DISCUSSION 
 
 The findings from the present study 
showed the average percentage of Salmonella 
isolates susceptible to antimicrobial agents tested 
ranged from 6.9% (tetracycline) to 98% 
(carbapenem and cefepime). There were varying 
degrees of susceptibility of isolates among 
individual drugs as well as geographical strains. 
Azithromycin though found to be 97% 
active against Salmonella spp. in the present 
study, findings from Egypt (Girgis, et al., 1999) 
showed a 100% activity against all the strains 
tested including the MDR strains. In Tadjikistan 
(Makhnev, 2003) on the other hand, azithromycin 
was found to be unable to produce a 100% 
activity, though a susceptibility of over 90% was 
severally recorded; and in Dong Thap province, 
Vietnam (Parry, et al., 2007), all the isolates of 
Salmonella spp. were found to be susceptible to 
azithromycin. Findings from Bangladesh 
(Isbandiro, et al., 1994) similarly showed a 
slightly higher susceptibility of 98% to 
azithromycin. 
The quinolones had a wide but varying 
range of activity against the Salmonella spp. 
though an average susceptibility of 73% was 
recorded in the present study. In Switzerland 
(Glauser, et al., 2002), a higher figure of 84% 
susceptibility was recorded among patients 
placed on clinafloxacin monotherapy. In Lagos, 
Nigeria (Akinyemi, et al., 2005), a much higher 
susceptibility of 98% to ciprofloxacin and 
ofloxacin was recorded, while in Zaria, Nigeria 
(Ibrahim, et al., 2005) sensitivity to nalidixic acid 
was found to be as low as 40%. In Kuwait 
(Dimitrov, et al., 2007), a much higher resistance 
(over 50%) to nalidixic acid was recorded as well 
as treatment failures to ciprofloxacin 
monotherapy, while a resistance of over 78% by 
Salmonella spp. to nalidixic acid was recorded in 
India (Kadhiravan, et al., 2005).  
Ceftriaxone and cefixime were found to 
have a susceptibility of 82% and 78% 
respectively with varying ranges along with the 
other cephalosporins. Susceptibility patterns of 
both drugs of over 95% have been recorded in 
some centres in both the United Kingdom 
(Threlfall, and Ward, 2001) and United States of 
America (Ackers, et al., 2000), with much lower 
susceptibility patterns (less than 60%) in several 
centres.  
The percentage susceptibility of 
Salmonella spp. to ampicillin, tetracycline, co-
trimoxazole, gentamicin, streptomycin, 
azithromycin and chloramphenicol was generally 
low (6.9% - 46%). This includes the findings of 
Ullah, et al, in Dera Ismail Khan, Pakistan (Ullah, 
et al., 2005), where 50%, 71.4%, and 75% 
resistance was recorded by the organism against 
chloramphenicol, amoxycilline and co-
trimoxazole respectively; the over 70% resistance 
recorded by similar drugs in Bangkok, Thailand 
(Isenberger, et al., 2002); and the report from Ho 
Chi Minh city, Vietnam (Smith, et al., 1994) where 
about 63% of the Salmonella isolates were found 
to be multiply resistant to chloramphenicol, 
ampicillin, co-trimoxazole, and tetracycline. 
Findings from Kolkata, India (Kundu. 2005) on 
the contrary showed a renewed increase in 
susceptibility to chloramphenicol. 
Considering the life threatening 
complications of untreated or improperly treated 
typhoid fever and, the high rate of resistance 
recorded by majority of the drugs for its 
treatment. Caution should be exercised in the 
selection of appropriate antibiotics for proper 
treatment. Selection of antibiotics for treatment of 
enteric fever should stem from a well conducted 
antimicrobial susceptibility report. Susceptibility 
tests should be carried out on all isolates of 
Salmonella spp. so as to adequately guide the 
personnel treating the patient and avoid relapse, 
a common phenomenon from drug failure.  
Susceptibility to carbapenem, amikacin, 
clavulanate potentiated amoxycillin and cefepime 
was in the range of 98%, 63%, 54.3% and 98% 
respectively. The carbapenems and the 4th 
generation cephalosporins are relatively new 
drugs whose prescriptions has not been 
documented in several hospitals and clinics 
across the world (Chande, et al., 2002; and, 
Corrado,  et al., 1992).and the extremely low 
resistance is expected. The susceptibility might 
be higher than this but for the interpersonal and 
procedural bias, which cannot be ruled out in a 
study of this magnitude.  
The susceptibility profile of the local 
Salmonella isolates against the common 
antibiotics in use should be known by the 
concerned health personnel. Such data should 
be reviewed periodically so as to reflect the 
current antibiotic susceptibility pattern of the 
organism for quick reference. This would be very 
useful when patients present in very critical 
states leaving little or no time to wait for the 
susceptibility report. Such data would even be 
more useful in the developing world where 
laboratory facilities for diagnosis are either 
inadequate or lacking and, often times laboratory 
 
results are not available on time. Furthermore, 
clinical diagnosis of enteric fever should be 
confirmed by laboratory investigations so as to 
reduce over diagnosis of enteric fevers.  This 
carries with it the attendant unnecessary and 
unjustifiable antibiotics consumption from 
empirical treatments and the subsequent 
development and spread of resistance. This 
scenario is often encountered in clinical practice 
especially in the developing world (Akin, et al., 
2003; and Kacprzak, et al., 2002). 
In conclusion, this review has found that, 
no single drug at present holds the absolute 
promise for the treatment of Salmonella 
infections and globally, there is a high resistance 
of Salmonella to majority of the drugs hitherto 
commonly used for its treatment. Quinolones, 
azithromycin, ceftriaxone, cefixime, carbapenem 
and cefepime are presently the drugs with the 
highest activity against Salmonella spp. and 
hence on a general note should be considered 
on isolation of Salmonella.  Efforts should be 
made to establish diagnosis of typhoid beyond 
doubt before treatment is started so as to avoid 
empirical prescriptions and unjustifiable 
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